These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells. O'Toole C, Saxon A, Bohrer R. Clin Exp Immunol; 1977 Jan; 27(1):165-71. PubMed ID: 300304 [Abstract] [Full Text] [Related]
23. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model]. Hori T, Kan N, Inamoto T, Nio Y, Ohgaki K, Kodama H, Tobe T. Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027 [Abstract] [Full Text] [Related]
24. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells. Warnatz H, Scheiffarth F, Schmeissner R. Clin Exp Immunol; 1975 Aug; 21(2):250-8. PubMed ID: 1081024 [Abstract] [Full Text] [Related]
25. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice. Higasa M, Yamada K, Takagaki Y, Aoki M, Shinka S, Dohi Y. Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518 [Abstract] [Full Text] [Related]
26. Changes in host immunity following excision of a murine melanoma. Bray AE, Keast D. Br J Cancer; 1975 Feb; 31(2):170-5. PubMed ID: 1164467 [Abstract] [Full Text] [Related]
27. Killer cell (K) activity in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Eremin O, Ashby J, Franks D. Int Arch Allergy Appl Immunol; 1977 Feb; 54(3):210-20. PubMed ID: 873621 [Abstract] [Full Text] [Related]
28. Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours. Baldwin RW, Glaves D, Vose BM. Br J Cancer; 1974 Jan; 29(1):1-10. PubMed ID: 4362448 [Abstract] [Full Text] [Related]
29. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro. Lynch DH, Gurish MF, Daynes RA. Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587 [Abstract] [Full Text] [Related]
30. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma. Werkmeister JA, Pihl E, Flannery GR. Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):115-24. PubMed ID: 7259635 [Abstract] [Full Text] [Related]
37. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. Fortner GW, Kripke ML. J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296 [Abstract] [Full Text] [Related]
38. Immunologic competence of regional lymph nodes in patients with breast cancer. Ellis RJ, Wernick G, Zabriskie JB, Goldman LI. Cancer; 1975 Mar; 35(3):655-9. PubMed ID: 1111934 [Abstract] [Full Text] [Related]
39. The nature of blood-borne cytotoxic cells. I. Cooperation between the white cells of the blood and lymph of sheep in the destruction of xenogeneic tumour cells in vitro. Grant CK, Glover DJ, Hall JG, Alexander P. Transplantation; 1974 Mar; 17(3):254-64. PubMed ID: 4814197 [No Abstract] [Full Text] [Related]